Ideals in arbitrary three-dimensional algebras
Indagationes Mathematicae · 2026-11 · 37 (6) · 2160-2190
DOI: 10.1016/j.indag.2026.06.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indagationes Mathematicae, 2026-11. Verfasst von M.V. Velasco und 2 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Granada Vice Chancellor's Office of Research and Knowledge Transfer, University of Granada Department of Didactics of Mathematics.
Abstract (Originalsprache)
In this paper, we study arbitrary (not necessarily associative) 3-dimensional algebras. Such an algebra A is determined by a basis and the corresponding multiplication table, which is specified by 27 structure constants. We describe all ideals of A, providing an explicit characterization of both 1-dimensional and 2-dimensional ideals. Moreover, we classify 2-dimensional ideals into 4 distinct types. We prove that A either has infinitely many ideals or at most 4. We also show that, in any case, the maximum number of 1-dimensional ideals is 3, while the maximum number of 2-dimensional ideals is 2. Finally, we present a class of algebras with a finite number of ideals that attain this theoretical maximum.
Förderung
- University of Granada Vice Chancellor's Office of Research and Knowledge Transfer
- University of Granada Department of Didactics of Mathematics
Zitieren
APA
Velasco, M., Rozikov, U., & Narkuziev, B. (2026). Ideals in arbitrary three-dimensional algebras. Indagationes Mathematicae, 37(6), 2160-2190. https://doi.org/10.1016/j.indag.2026.06.002
Vancouver
Velasco M, Rozikov U, Narkuziev B. Ideals in arbitrary three-dimensional algebras. Indagationes Mathematicae. 2026;37(6):2160-2190. doi:10.1016/j.indag.2026.06.002
BibTeX
@article{Velasco2026,
author = {Velasco, M.V. and Rozikov, U.A. and Narkuziev, B.A.},
title = {Ideals in arbitrary three-dimensional algebras},
journal = {Indagationes Mathematicae},
year = {2026},
volume = {37},
number = {6},
pages = {2160--2190},
doi = {10.1016/j.indag.2026.06.002}
}
EUVIMED